Aldevron News

Aldevron appoints Jenny Stafford as Vice President and General Manager

Aldevron_Jenny_Stafford.jpg(FARGO, ND) Aldevron, a leading provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, announces the appointment of Jenny Stafford as Vice President and General Manager. Ms. Stafford’s responsibilities include overseeing the company’s manufacturing and client relations operations in Fargo, ND.

“We are pleased to have Ms. Stafford assume the newly created position of Vice President and General Manager,” said Michael Chambers, President and CEO of Aldevron. “Ms. Stafford has distinguished herself over the past 2 ½ years at Aldevron as Director of Quality and Regulatory by building an outstanding quality organization, leading the company’s compliance efforts, and directly supporting our clients’ needs. Her expertise and experience will play a crucial role as we grow the company to serve the expanding biologics manufacturing market.”

Prior to Aldevron, Ms. Stafford held positions of increasing responsibility at LifeCell Corporation, Merck Pharmaceuticals and PRACS Institute. Her responsibilities included managing quality systems for compliance with international GMP and GLP regulations in the pharmaceutical, medical device, and human tissue production industries.

“I am excited to accept this new role at a pivotal time in the company’s development,” said Ms. Stafford. “Aldevron has a tremendous reputation and is positioned to make a significant impact by supporting our clients pursuing treatments for conditions with severe unmet needs. I look forward to contributing to the future success of the company as we expand our capacity and capabilities from research grade through commercial GMP production.”

Ms. Stafford holds a Master’s degree in Chemistry from North Dakota State University and a Bachelor of Science degree in Chemistry from Mayville State University.

About Aldevron

Aldevron offers development services and custom manufacturing of nucleic acids, proteins and antibodies, providing companies with essential components for research, clinical and commercial applications. Aldevron’s services include GMP-Source™ and GMP plasmid manufacturing, linear DNA and mRNA production, gene synthesis, RNA synthesis enzymes, and humanized and recombinant antibody generation. Aldevron’s collaborative approach and commitment to providing quality materials allow it to meet precise client requirements and provide innovative solutions to advance science. Aldevron is headquartered in Fargo, North Dakota, and has facilities in Madison, Wisconsin, and Freiburg, Germany.

Topics: Corporate News

Comments